| |
|
|
|
Summit Therapeu ADR  
|
|
6.38 -0.11 (-0.02%) |
09-17 16:00 |
|
Open: |
6.54 |
Pre close: |
6.49 |
Target:
|
8.82
|
|
High: |
6.74 |
Low: |
6.29 |
Resistance:
|
7.55
8.39
|
|
Volume: |
473,445 |
Market Cap: |
621M |
Support:
|
6.21
5.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.40
 |
MACD |
MACD(12,26):
|
-0.35 |
|
MA(20): |
7.23 |
Signal(12,26,9): |
-0.26 |
|
MA(100): |
7.21  |
Stochastic Oscillator |
%K(14,3):
|
10.42 |
|
MA(250): |
6.05 |
%D(3): |
9.71 |
|
Average Volume(K) |
3-Month: |
578185
|
52-Week |
High:
|
12.30 |
|
10-Days: |
139061 |
Low: |
3.15 |
|
RSI |
RSI(14):
|
35.16 |
Change(%): |
85.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.870 |
Return on Equity (ttm) |
-96.8 |
Shares Out. (M) |
97.24 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-32.5 |
Shares Float (M) |
24.64 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
74.08 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
-40.7 |
% Held by Institutions |
9.68 |
|
Forward EPS |
0.118 |
Gross Profit (p.s.) |
0.009 |
Shares Short (K) |
811 |
|
Book Value (p.s.) |
0.780 |
EBITDA (p.s.) |
-0.600 |
P/E |
-7.33 |
|
Sales Per Share |
0.007 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-63.82 |
P/S |
852.18 |
|
Operating Margin |
-8230.36 |
Levered Free Cash Flow
(M) |
-36.13 |
P/CF |
-9.72 |
|
|
|
|
|
|
